A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care
In response to emailed questions, the founders of MucoLife Therapeutics shared their company's approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis.